DEFENDER Overview
- Website
- defender-project.org
- Industry
- Biotechnology Research
- Employees
- 31
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About DEFENDER
The COVID-19 pandemic has highlighted the immense risk potential posed by (re‑)emerging viruses. There are neither approved vaccines nor specific therapies for many of these viruses. This is precisely where DEFENDER (IDEntification oF novel viral Entry factors aNd DevelopmEnt of antiviRal approaches) comes in: The project aims to develop new, alternative antiviral approaches in order to be prepared for future outbreaks.
Compare Similar Companies to DEFENDER
European Centre for Disease Prevention and Control (ECDC)
Government Administration
Leibniz-Institut für Virologie (LIV)
Research Services
Insempra
Biotechnology Research
WHO Hub for Pandemic and Epidemic Intelligence
International Affairs
Famiglia Desideri - Cialde di Montecatini Terme
Food And Beverage Manufacturing
Defender Pro LLC
Software Development
Hotel Montecatini Terme-Tuscany
Hospitality
SHIELD - Molecular Strategies against Viral Entry and Glycan Shielding
Research Services
Junior Section SFBBM
Civic And Social Organizations
Research Training Group 2633
Higher Education